MedPath

Clemastine Fumarate

Clemastine Fumarate

Approved
Approval ID

be4f8613-e4da-45e1-a5c0-e9337ca5d245

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 21, 2014

Manufacturers
FDA

Northwind Pharmaceuticals, LLC

DUNS: 036986393

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Clemastine Fumarate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51655-425
Application NumberANDA073283
Product Classification
M
Marketing Category
C73584
G
Generic Name
Clemastine Fumarate
Product Specifications
Route of AdministrationOral
Effective DateJuly 21, 2014
FDA Product Classification

INGREDIENTS (1)

CLEMASTINE FUMARATEActive
Quantity: 2.68 mg in 1 1
Code: 19259EGQ3D
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.